Juan Vera Insider Trading $ALVR Allovir, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Juan Vera.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Juan Vera. Juan Vera is Chief Development Officer in Marker Therapeutics, Inc. ($MRKR) and Director in Marker Therapeutics, Inc. ($TPIV) and Director in Allovir, Inc. ($ALVR).
Juan Vera in Allovir, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Juan Vera: Director
Holdings: 2,392,194 shares
Latest Transaction: Mar 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Juan Vera in Allovir, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.63 | 7,546 | 291,518 | 2,339,928 | 2.3 M to 2.3 M (-0.32 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.22 | 7,142 | 272,954 | 2,347,474 | 2.4 M to 2.3 M (-0.30 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 37.01 | 1,300 | 48,114 | 2,354,616 | 2.4 M to 2.4 M (-0.06 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 39.10 | 1,803 | 70,500 | 2,355,916 | 2.4 M to 2.4 M (-0.08 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.30 | 9,001 | 344,708 | 2,357,719 | 2.4 M to 2.4 M (-0.38 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 37.28 | 4,190 | 156,189 | 2,366,720 | 2.4 M to 2.4 M (-0.18 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 39.53 | 700 | 27,671 | 2,370,910 | 2.4 M to 2.4 M (-0.03 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.73 | 20,584 | 797,266 | 2,371,610 | 2.4 M to 2.4 M (-0.86 %) |
| Mar 03 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.28 | 11,570 | 442,842 | 2,392,194 | 2.4 M to 2.4 M (-0.48 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 40.97 | 600 | 24,582 | 2,403,764 | 2.4 M to 2.4 M (-0.02 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 40.13 | 2,300 | 92,294 | 2,404,364 | 2.4 M to 2.4 M (-0.10 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 39.11 | 4,825 | 188,692 | 2,406,664 | 2.4 M to 2.4 M (-0.20 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.33 | 1,125 | 43,116 | 2,411,489 | 2.4 M to 2.4 M (-0.05 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 43.40 | 380 | 16,493 | 2,412,614 | 2.4 M to 2.4 M (-0.02 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 42.80 | 11,050 | 472,907 | 2,412,994 | 2.4 M to 2.4 M (-0.46 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 41.58 | 2,891 | 120,215 | 2,424,044 | 2.4 M to 2.4 M (-0.12 %) |
| Feb 23 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 41.79 | 13,233 | 553,011 | 2,426,935 | 2.4 M to 2.4 M (-0.54 %) |
| Feb 19 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 41.49 | 3,710 | 153,923 | 2,440,168 | 2.4 M to 2.4 M (-0.15 %) |
| Feb 19 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 40.44 | 4,032 | 163,069 | 2,443,878 | 2.4 M to 2.4 M (-0.16 %) |
| Feb 19 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 39.48 | 1,200 | 47,376 | 2,447,910 | 2.4 M to 2.4 M (-0.05 %) |
| Feb 18 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 41.26 | 4,060 | 167,507 | 2,449,110 | 2.5 M to 2.4 M (-0.17 %) |
| Feb 18 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 40.00 | 1,400 | 56,003 | 2,453,170 | 2.5 M to 2.5 M (-0.06 %) |
| Feb 18 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 38.71 | 2,000 | 77,421 | 2,454,570 | 2.5 M to 2.5 M (-0.08 %) |
| Feb 18 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 42.53 | 966 | 41,081 | 2,456,570 | 2.5 M to 2.5 M (-0.04 %) |
| Feb 18 2021 | ALVR | Allovir, Inc. | Vera Juan | Director | Sell | S | 41.79 | 9,434 | 394,284 | 2,457,536 | 2.5 M to 2.5 M (-0.38 %) |
| Aug 06 2020 | ALVR | Allovir, Inc. | Vera Juan | Director | Option Exercise | C | 0.00 | 3,631,293 | 0 | 0 | |
| Aug 06 2020 | ALVR | Allovir, Inc. | Vera Juan | Director | Buy | C | 0.00 | 2,436,773 | 0 | 2,466,970 | 30.2 K to 2.5 M (+8,069.59 %) |
| Jul 31 2020 | ALVR | Allovir, Inc. | Vera Juan | Director | Option Exercise | A | 17.00 | 22,500 | 382,500 | 22,500 |
Page: 1